Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China · Delayed Price · Currency is CNY 40.30
-0.59 (-1.44%)
Jul 25, 2025, 3:04 PM CST
SHE:002773 Revenue
Chengdu Kanghong Pharmaceutical Group had revenue of 1.20B CNY in the quarter ending March 31, 2025, with 9.70% growth. This brings the company's revenue in the last twelve months to 4.56B, up 9.44% year-over-year. In the year 2024, Chengdu Kanghong Pharmaceutical Group had annual revenue of 4.45B with 12.51% growth.
Revenue (ttm)
4.56B
Revenue Growth
+9.44%
P/S Ratio
8.14
Revenue / Employee
1.02M
Employees
4,462
Market Cap
37.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.45B | 495.20M | 12.51% |
| Dec 31, 2023 | 3.96B | 568.43M | 16.77% |
| Jan 1, 2023 | 3.39B | -216.32M | -6.00% |
| Jan 1, 2022 | 3.61B | 309.92M | 9.40% |
| Dec 31, 2020 | 3.30B | 38.00M | 1.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |